1-5 of 5
Junichi Sakamoto, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Kazunori Murai, MD, PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD, PhD, Takuto Miyagishima, MD, PhD, Motohiro Shindo, MD PhD, Kentaro Wakasa, MD, PhD, Mitsue Inomata, MD, PhD, Takahiro Nagashima, MD, PhD, Takeshi Kondo, MD PhD, Nozomu Fujimoto, MD, PhD, Satoshi Yamamoto, PhD MD, Masakatsu Yonezumi, MD, PhD, Tatsuo Oyake, MD, PhD, Shugo Kowata, MD PhD, Yasuhiko Tsukushi, MD PhD, Takahiro Mine, MD, Kuniaki Meguro, MD PhD, Kazuhiko Ikeda, MD PhD, Reiko Watanabe, MD PhD, Souichi Saito, MD, PhD, Shinji Sato, MD, PhD, Takaaki Chou, MD, PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3102.
https://doi.org/10.1182/blood.V128.22.3102.3102
Published: 2016
Journal Articles

Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib

Kazunori Murai, MD PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD PhD, Tomoaki Akagi, Kazuei Ogawa, MD PhD, Inomata Mitsue, Kuniaki Meguro, Reiko Watanabe, MD PhD, Takuto Miyagishima, MD, PhD, Kentaro Wakasa, Motohiro Shindo, MD PhD, Yasuhiko Tsukushi, MD PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 4052.
https://doi.org/10.1182/blood.V126.23.4052.4052
Published: 2015
Journal Articles

Management of Adverse Events Associated with Dasatinib during Early Periods of Therapy in the Treatment of Chronic Myeloid Leukemia -a Clinical Report of Daria-01 Study

Shuichi Mizuta, MD, Hisashi Tsurumi, Masashi Sawa, MD PhD, Kana Matsumoto, PhD, Kotaro Miyao, MD, Takeshi Hara, MD PhD, Takeshi Takahashi, MD PhD, Reona Sakemura, MD, Akio Kohno, MD PhD, Mari Oba, Satoshi Morita, PhD, Junichi Sakamoto, MDPhD, Nobuhiko Emi, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4537.
https://doi.org/10.1182/blood.V124.21.4537.4537
Published: 2014
Journal Articles

The Incidence of Pleural Effusion on Dasatinib Treatment Is Associated with CD56 Positive Cell Values One Month after Commencing Dasatinib and Achievement of an Early Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia Patients: Results of a D-First Study

Noriyoshi Iriyama, Shin Fujisawa, MD, Maki Hagihara, MDPhD, Chikashi Yoshida, MD PhD, Hisashi Wakita, MD PhD, Shigeru Chiba, MD PhD, Shinichiro Okamoto, MD PhD, Kawakami Kimihiro, Naoki Takezako, MD PhD, Takashi Kumagai, MD PhD, Koiti Inokuchi, MD PhD, Kazuma Ohyashiki, Jun Taguchi, MD PhD, Shingo Yano, Tadahiko Igarashi, MD PhD, Yasuji Kouzai, MD PhD, Satoshi Morita, PhD, Junichi Sakamoto, MDPhD, Hisashi Sakamaki, MDPhD
Journal: Blood
Blood (2014) 124 (21): 3142.
https://doi.org/10.1182/blood.V124.21.3142.3142
Published: 2014
Journal Articles

A Shorter Halving Time for BCR-ABL transcript Reduction Is a Novel Predictor of Molecular Response Achievement in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patients Treated with Dasatinib: Results of D-First Study

Maki Hagihara, MDPhD, Noriyoshi Iriyama, MDPhD, Chikashi Yoshida, MD PhD, Shin Fujisawa, MD, Hisashi Wakita, MD PhD, Shigeru Chiba, MD PhD, Naoki Takezako, MD PhD, Kimihiro Kawakami, MD PhD, Shinichiro Okamoto, MD PhD, Koiti Inokuchi, MD PhD, Kazuma Ohyashiki, Takashi Kumagai, MD PhD, Jun Taguchi, MD PhD, Shingo Yano, Tadahiko Igarashi, MD PhD, Yasuji Kouzai, MD PhD, Junichi Sakamoto, MDPhD, Satoshi Morita, PhD, Hisashi Sakamaki, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1795.
https://doi.org/10.1182/blood.V124.21.1795.1795
Published: 2014